The novel drug reconstitution systems have emerged as a promising alternative to traditional methods of reconstitution, adding significant value to the storage and transfer of lyophilized therapeutics. These systems enhance the portability, efficiency and optimum delivery of the lyophilized drugs and have the potential to reduce the number of steps significantly, which enable the dilution and reconstitution at the time of delivery. Owing to several other benefits, novel drug reconstitution systems are gradually gaining popularity in the packaging industry.
Players Engaged in Manufacturing Novel Drug Reconstitution Systems
During our research, we came across more than 35 players, which claim to offer 55+ novel drug reconstitution systems. As per our analysis, majority of these players are located in Europe, followed by Asia-Pacific.
Want additional details on the pipeline? It is just a click away.
Further, we also came across players, which claim to offer one step reconstitution systems and conventional reconstitution devices.
Increase in Drug Approvals is believed to raise the Demand for Packaging Containers
In order to cope up with the prevalent and upcoming trends of packaging parenteral formulations, the packaging industry is steadily evolving to cater to the changing needs of drug manufacturers.
High Number of Patents are Suggestive of the Widespread Research in this Domain
Several industry and non-industry players are involved in the manufacturing of drug reconstitution systems. The field has seen a significant rise in the number of patents over the past decade, with Sanofi leading the way in terms of the total number of patents filed / granted.
Events related to Drug Reconstitution Systems, organized Globally
The rising demand for efficient drug reconstitution systems with improved safety has prompted several stakeholders to develop innovative devices / systems, which ease the process of reconstitution of lyophilized therapeutics. Industry stakeholders are increasingly participating in the conferences / seminars / summits / workshops in order to highlight their initiatives and develop more understanding on the optimal and accurate reconstitution of lyophilized medications.
What is the Current Demand for Novel Drug Reconstitution Systems (in terms of number of units)?
Over the past decade, the number of novel drug reconstitution systems available in the market have increased significantly. In fact, the increase in demand for these reconstitution systems, is reported to be driven by the increase in lyophilized therapeutics. In order to address this increasing demand, developer companies are continuously working towards the development of more sophisticated and easier to use reconstitution systems.
Future Evolution of Novel Drug Reconstitution Systems Market
Owing to the rise in adoption of novel drug reconstitution systems in healthcare departments, we anticipate the overall market to grow at a CAGR of greater than 5%.
Given the rise in efforts to improve the reconstitution and storage of lyophilized therapeutics and the ongoing pace of research in the self-injection industry, novel drug reconstitution systems are set to make the life-cycle management easier and more convenient. With the rising demand for lyophilized drugs and dual / multi chamber systems addressing the key requirements for their delivery, the future opportunity for stakeholders is projected to grow at a noteworthy pace over the next decade.
For further information on this domain, check out the report –